Alois B. Lang
Corporate Officer/Principal bij University of Bern
Actieve functies van Alois B. Lang
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| University of Bern | Corporate Officer/Principal | - | - |
Loopbaan van Alois B. Lang
Eerdere bekende functies van Alois B. Lang
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| GENEURO SA | Corporate Officer/Principal | - | 31-12-2018 |
Kenta Biotech AG
 Kenta Biotech AG BiotechnologyHealth Technology Kenta Biotech AG engages in the research, development, production, and marketing of biotechnological and pharmaceutical products. It also specializes in the discovery and development of monoclonal antibodies for the treatment of life-threatening hospital infections. The company was founded by Alois B. Lang on February 9, 2006 and is headquartered in Zug, Switzerland. | Hoofd Techniek/Wetenschap/O&O | 02-09-2006 | - |
| Oprichter | 02-09-2006 | - |
Opleiding van Alois B. Lang
| Swiss Federal Institute of Technology | Doctorate Degree |
Statistieken
Internationaal
| Zwitserland | 5 |
Operationeel
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoraal
| Consumer Services | 3 |
| Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| GENEURO SA | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Kenta Biotech AG
Kenta Biotech AG BiotechnologyHealth Technology Kenta Biotech AG engages in the research, development, production, and marketing of biotechnological and pharmaceutical products. It also specializes in the discovery and development of monoclonal antibodies for the treatment of life-threatening hospital infections. The company was founded by Alois B. Lang on February 9, 2006 and is headquartered in Zug, Switzerland. | Health Technology |
- Beurs
- Insiders
- Alois B. Lang
- Ervaring
